FDA
-
-
-
-
-
-
-
Kamada receives FDA approval for San Antonio plasma collection center
-
-
-
-
-
-
-
Kamada Provides 2026 Annual Guidance of $200 - $205 Million in Revenues and $50 - $53 Million of Adjusted EBITDA, Representing Double-Digit Growth and Affirms 2025 Financial Guidance
-
-
-
-
-
-
-
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025
-
-
-
-
-
-
-
Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East
-
-
-
-
-
-
-
Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas
-
-
-
-
-
-
-
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
-
-
-
-
-
-
-
Kamada to Announce Second Quarter and First Half Ended June 30, 2024 Financial Results and Host Conference Call on August 14, 2024
-
322,242 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

